Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
CogState Ltd
CGSCogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia. Address: 367 Collins Street, Melbourne, VIC, Australia, 3000
Analytics
Precio Objetivo de WallStreet
2.23 AUDRelación P/E
19.3Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave CGS
Análisis de dividendos CGS
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout CGS
Valoración de la acción CGS
Finanzas CGS
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |